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Estimates were made ofthe proportion ofchemicals thatwere carcinogenic,anticarcinogenic, or
either in 397 long-term bioassays conducted by the National Toxicology Program (NTP). The
estimates were obtained from the global pattern ofp-values obtained from statistical tests.
applied to individual experiments. These tests accounted for multiple comparisons using a ran-
domization procedure and were found to operate at the correct level of significance.
Reprsentative estimates ofthe prportion ofcarcinogens [with 90% confidence intervals (CI)]
compared to the NTP estes were as ollows: male mice, 0.32 (CI, 0.19-0.44), NTP _ 0.29;
female mice, 0.28 (CI, 0.15-041), NTP m 0.34; male rats, 0.35 (CI, 0.23-0.47), NTP - 0.36;
female rats, 0.34 (CI, 0.21-0.46), NTP = 0.28; all sexesand species, 0.59 (CI, 0.494.69), NTP
=0.51. Represntative estmates oftheproportion ofanticarcinogenswere asfollows: male mice,
0.34; female mice, 0.27; male rats, 0.40; female rats, 0.44; all sees and species, 0.66. Thus,
there was as much or more evidence in this study for anticarciogenesis as carcinogenesis. Even
though.the estimators usd were netive biased, it was estimated that 85% ofthe chemnicals
were either carcinogenic or anticarciogemc at some site in some sex-species group. This sug-
gests that most emics given at high enough doses will cause some sort ofperturbation in
tumor rates. Key word*t anticarcinogens, carcinogens, meta-anabsis, NTP bioassays, POLY3
test. Environ Healt Perpct107:83-88 (1999). [Online 16 December 1998]
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The National Cancer Institute and, more
recently, the National Toxicology Program
(NTP) have been routinely testing chemicals
for carcinogenic potential in long-term
rodent bioassays for about 25 years (1-3).
Most of the chemicals have been tested in
separate groups of animals composed of
males and females of two species (generally
rats and mice). These bioassays were initially
designed to screen for potential human car-
cinogens, and it was anticipated that further
studies would be conducted on the chemi-
cals identified as carcinogenic. Because NTP
bioassays involve relatively fewanimals (gen-
erally 50 animals are tested at each of2 or 3
dose levels, in addition to 50 control ani-
mals, in each of the 4 sex-species groups),
relatively high doses were used to minimize
the possibility that a potential human car-
cinogen would not be identified (3,4).
Because of financial and time constraints,
followup studies have often not been con-
ducted, and results from NTP bioassays
have been used extensively in the regulation
ofchemicals-not only to identify potential
carcinogenic hazards to humans, but also to
determine dose-response relationships.
More than 400 chemicals have been test-
ed to date by the NTP, about one-half of
which have been identified as carcinogenic in
at least one sex-species group (1-3). Some
researchers have expressed concern at finding
such a high percentage of carcinogens and
believe that many of these carcinogenic
responses are generalized indirect reactions
to high-dose toxicity, which consequently
may not be relevant to humans exposed to
much lower levels (5). On the other hand, it
has been pointed out that most chemicals
were selected for testing by the NTP
because they were suspected carcinogens
and are not necessarily representative ofall
chemicals in commercial use (3,6,7).
In the current study, we developed inde-
pendent estimates of the proportions of
chemicals that were carcinogenic in each
sex-species group, as well as the proportion
of chemicals that were carcinogenic in any
group, among chemicals tested by the NTP,
and compared these estimates to the pro-
portions identified by the NTP. We also
estimated the proportions ofchemicals that
were anticarcinogenic (i.e., caused dose-
related decreases in tumor incidence in one
or more tumor categories) and the propor-
tions that were either carcinogenic or anti-
carcinogenic. The NTP did not routinely
evaluate chemicals for anticarcinogenesis.
These estimates are based on a substan-
tially different methodology (8-11) than
that used by the NTP to identify carcino-
gens. Unlike the NTP approach, the esti-
mation procedure used here did not involve
determination of whether an individual
chemical was carcinogenic. Rather, we
examined the overall distribution ofp-val-
ues obtained from statistical tests applied to
each ofthe NTP bioassays. Ifthere were no
carcinogens present, these p-values would
theoretically be uniformly distributed. The
proportion ofcarcinogens is estimated from
the pattern of departure from the uniform
distribution. The approach does not rely on
a single cutoff for p-values (e.g., p = 0.05)
and accounts appropriately for the propor-
tion ofp-values in any range (e.g., an excess
ofp-values in the range 0.1-0.2, or a deficit
in the range 0.8-1.0).
Using a similar methodology, Crump et
al. (10) estimated that there were apprecia-
bly more liver carcinogens (166) among
390 NTP bioassays than were identified by
the NTP (108). Other studies (12-14) have
examined the frequency of carcinogenic or
anticarcinogenic responses in the NTP
database. However, these investigations
focused on specific levels ofstatistical signif-
icance (e.g., 0.05 or 0.01). We believe that
the methodology used in the current paper,
which exploits the entire distribution ofp-
values, may allow for a more definitive
assessment of carcinogenesis and anticar-
cinogenesis in NTP bioassays.
Methods
This studywas based on datafrom 397 long-
term carcinogenicity bioassays conducted by
the NTP (10) and stored in either the
Carcinogenesis Bioassay Data Base (CBDS;
320 studies), or its successor, the Toxicity
Data Management System (TDMS; 77 stud-
ies). Most ofthese studies involved mice and
rats, and our analysis was restricted to these
two species. Generally, males and females of
a species were tested in separate experiments,
most ofwhich involved two or three dose
levels, in addition to a control group. The
highest dose used in each experiment was an
estimate of the maximum tolerated dose.
Most ofthe experiments used 50 animals per
dose group, although control groups in a few
of the earlier studies contained as few as 10
animals. Experiments that the NTP consid-
ered inadequate for determining carcino-
genicitywere eliminated, which left a total of
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Table 1. Numbers of studies with various NTP classifications and percent significant (pO0
sent analysis
NTP classifications
Positive (%) Equivocal (%) Negative (%) Con
Male mice 108(90.7) 45(33.3) 214(4.7)
Female rice 129 (87.6) 24(29.2) 220(8.2)
Male rats 130 (76.9) 42(28.6) 194(6.2)
Female rats 103 (83.5) 38 (26.3) 226 (4.4)
All sexes and species 201 (83.1) 60 (21.7) 136 (7.4)
aPercentage of experiments classified as positive by NTP with POLY3 p-value.0.05, plus percentage of experimentscia;
or negative bythe NTPwith p-value >0.05.
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367 experiments involving male mice, 373
offemale mice, 366 ofmale rats, and 367 of
female rats, which collectively tested a total
of397 chemicals (more precisely, chemical-
exposure route categories, as a few chemicals
were tested by different routes). A designa-
tion of "inadequate" usually resulted from
either 1) a determination that the experi-
mental animals did not survive long enough
to provide an adequate test ofcarcinogenici-
ty or 2) a determination that the test ani-
mals in the high-exposure group could have
withstood ahigher exposure.
We developed estimates of the propor-
tion ofcarcinogenic chemicals in each ofthe
four sex-species groups and of the propor-
tion thatwere carcinogenic in any one ofthe
four groups. We developed corresponding
estimates for the proportion of chemicals
that were anticarcinogenic or either carcino-
genic or anticarcinogenic. A chemical could
'P
_l 1. Clt9imu tiVe distbutic
(CDF)'of,pdy*Iuh of st forcaia
: 3A70 sot. ol
be dassified as both carcinoger
carcinogenic if it caused a c
increase in tumor incidence at
dose-related decrease at a differe
The estimation procedure u
from statistical hypothesis test
individual sex-species experin
p-values were derived from aF
the POLY3 test for a treatn
trend in tumor incidence (15)
all ofthe dose groups on each
of individual tumor categoric
present in a given sex-species
After evaluating a number
tests, we selected the POLY3
significance levels from this to
to be closest to the nominal va]
Although the POLY3 test ha
used historically by the NTP, i
ly become the NTP's preferred
analyzing animal carcinogenicit
Categories oftumors that were subjected
'.05) in the pre- to statistical analysis were definedsimilarlyto
the categories routinelyanalyzed bythe NTP
and were reviewed by Joseph Haseman of
cordancea l the NTP forconsistency with NTPpractice.
90.5 There was a total of93 possible tumor cate-
89.0 gories for CBDS studies and 79 for TDMS
85.2 studies. The test statistic, T, for an effect in a
89.9 sex-species experiment was the largest ofthe
85.6 POLY3 test statistics, after application of a
ssified asequivocal continuity correction, derived from any
tumorcategory. To ensure that the test based
on Thad the proper false positive rate, itsp-
value was determined using a randomization
procedure (18,19). In this procedure animals
from a given sex-species experiment were
; = t randomly reassigned to treatment groups a
total of400 times, and the POLY3 was reap-
plied to each set of randomized data. To
~ control for potential differences in life span
oj s among different treatment groups, in these
random reassignments animals were strati-
fied into four groups according to elapsed
time from beginning of study until death,
and the total number of animals in each
treatment-time category was kept fixed at its
value in theoriginal data. Thep-value for the
teststatistic, T, was defined as theproportion
oftimes (out ofa total of400) forwhich the
largest POLY3 test statistic from the ran-
domly created data sets equaled or exceeded
BAi 1'. :T Thep-value for a test for an effect in any
sex-species experiment was defined as 1 - (1
- Pmin)k where Pmin was the minimum p-
value from all sex-species experiments, and k
was the number of such experiments in a
study (in the majorityofstudies, k= 4).
WfunEtions The estimate used for the proportion of rcitogenicit positive experiments was
$ulmtod
K(a) = [F(a) -a]/(1 - a),
where F(a) was the empirical distribution
nic and anti- function ofp-values [i.e., F(a) was the pro-
lose-related portion of experiments in which the p-
ne site and a value was <a]. Ifthe statistical test is oper-
nt site. ating at the correct level of significance
isedp-values (e.g., if its p-value is uniformly distributed
:s applied to whenever treatment does not affect tumor
ients. These rates) then the estimator, K(a), is negatively
)plication of biased for every value of a, and the bias of
ient-related K(a) decreases, and its variance increases, as
to data from aapproaches 1 (8,11).
ofa number A simulation was conducted to deter-
es that were mine the properties of the estimator K(a)
experiment. in the null case (i.e., the situation in which
f statistical none ofthe chemicals studied by the NTP
test because were either carcinogenic or anticarcino-
est appeared genic). In this exercise, a set of null data
lues (10,16). was fabricated for each NTP experiment by
id not been randomly reassigning animals in the man-
it has recent- ner described earlier. Then our estimation
I method for procedure was applied to the set of fabri-
y data (17). cated data rather than to the actual data.
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To reduce the effect of random variation,
this procedure was repeated 10 times for
each experiment, and the estimator K(a)
calculated from the combined data. To
reduce the amount of computer time
required, p-values were based on 100 ran-
dom assignments, rather than 400.
Results
Originally, the NTP classified individual
tumor categories as P (positive for carcino-
genicity), E (equivocal), N (negative), or I
(inadequate). Later the classification scheme
was changed to CE (clear evidence), SE
(some evidence), EE (equivocal evidence),
NE (no evidence), and IS (inadequate
study). To have a common classification
system for all NTP studies, we designated
P, CE, and SE as positive (P), E and EE as
equivocal (E), and N and NE as negative
(N). Data from experiments with a dassifi-
cation of I or IS were not used. An experi-
ment was then dassified by the highest clas-
sification of any tumor site (i.e., if at least
one tumor category was dassified as P, then
the experiment received that classification;
otherwise, ifatleast one tumor categorywas
classified as E, then the experiment received
that dassification, otherwise the experiment
was classified as N). The same procedure
was used to categorize a study based on the
experiment-wise classifications.
Table 1 compares the carcinogenicity
dassifications obtained by the NTP (modi-
fied as explained in the previous paragraph)
to those obtained from our analysis using a
conventional significance level of 0.05.
Experiments classified by the NTP as posi-
tive had p-values <0.05 in our analysis in
91% of male mice experiments, 88% of
female mice experiments, 77% of male rat
studies, and 84% offemale rat experiments.
Correspondence was better in experiments
classified as negative by the NTP, as only
4.4-8.2% of these had p-values <0.05.
Between 26 and 33% of the studies dassi-
fied as equivocal by the NTP had p-values
<0.05. In overall study classifications, a p
value <0.05 was obtained in 84% of the
studies classified as positive by the NTP,
7.4% of those classified as negative, and
22% ofthose classified as equivocal.
Figure 1 shows the cumulative distribu-
tions ofp-values obtained from the simula-
tion ofthe null case in which treatment has
no effect on tumor rates. Each of the sex-
and species-specific distributions appear to
be a good approximation to the uniform
distribution (represented by the line y = x),
a condition that is required for the theoret-
ical properties ofour estimation procedure
(described in the Methods section). The
greatest departure from the uniform distri-
bution occurred in the case offemale mice,
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where the cumulative distribution function
(CDF) graph lay slighdy below the line y =
x for values of p between 0.5 and 0.9. If
this tendency occurred in the real data, it
would result in a slight underestimate of
the proportion of carcinogens. The simu-
lated cumulative distribution for all sexes
and species is more irregular and has a
"sawtooth" appearance for small values of
p. This effect is apparently due to the limit-
ed number ofreassignments used to calcu-
late a p-value. Because only 100 reassign-
ments were used in this simulation study,
the smallest possible nonzero sex- and
species-specific p-value was 0.01. However,
the smallestp-value for all sexes and species
was larger, and in most studies (those stud-
ies involving mice and rats ofeach sex for a
total offour experiments) was
1 - (1
_ 0.01)4 = 0.0394.
This "sawtooth effect" would be less of a
factor in the analyses of the actual data,
where 400 reassignments were conducted.
However, even with 10Q reassignments, the
cumulative distribution for all sexes and
species appears to closely approximate the
line y = xfor largerp-values (e.g., larger than
0.6), which is the range ofp-values ofprinci-
pal interest in our estimation procedure.
Figure 2 displays the cumulative distri-
butions ofp-values obtained for the actual
Figure 2 Cumulative distribution functIois
*('{CDF).. w f t.O for. ciroin ic lty
data. In contrast to the simulated distribu-
tions obtained for the null situation, these
distributions show significant departures
above the line y = x, indicative of a carcino-
genic effect in many experiments. The
largest such departure occurs, as expected,
in the graph for all sexes and species.
Figure 3 shows values of the estimator
K(a) ofthe proportion ofcarcinogens, with
corresponding 90% confidence intervals, as
a function ofthe parameter a. The horizon-
tal line in these graphs represents the pro-
portion of carcinogens based on the NTP
classifications (Table 1). Recall that K(a) is
negatively biased for all values of a, and this
bias decreases with increasing a. However,
the variance of K(a) increases with increas-
ing a, which accounts for the fact that confi-
dence intervals in Figure 3 become progres-
sively wider as a increases. These properties
suggest emphasizing estimates associated
with larger values of a, but not so large that
the confidence intervals become excessively
wide. The estimates for male and female
mice and male rats agree closely with the
proportion of carcinogens obtained by the
NTP over a range ofvalues of a. Although
our estimates are above the NTP proportion
over an extended range of a values for
female rats and for all sexes and species, the
90% confidence intervals on our estimates
generally incorporate the proportion of car-
cinogens identified bythe NTP.
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Figures 4 and 5 show, respectively, esti-
mates ofthe proportions ofanticarcinogens
and the proportions ofchemicals that were
either carcinogenic or anticarcinogenic.
Comparing Figures 3 and 4, except for
female mice, there is evidence of an equal
or greater proportion of anticarcinogens
than carcinogens. For all sexes and species,
estimates ofthe proportions ofcarcinogens
plus estimates ofthe proportion ofanticar-
cinogens exceeds 1 over a large range of
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values ofa. This suggests that a number of
chemicals were both carcinogenic and anti-
carcinogenic-causing dose-related increas-
es in tumors in at least one site in one
sex-species group and dose-related decreas-
es at another site.
Table 2 displays estimates of the pro-
portion of chemicals that were carcino-
genic, anticarcinogenic, or either based on
the specific value a = 0.75. This value was
selected as representative based on the
trade-off of having a large in order to
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reduce bias, but not so large that the vari-
ance was excessively large. Table 2 also
shows the proportions of carcinogens
identified by the NTP. Our estimates of
the proportion of carcinogens in the dif-
ferent sex-species groups were similar,
ranging from 0.28 in female mice to 0.35
in male rats. These estimates are also fair-
ly similar to the NTP proportions. Our
estimate of the proportion of chemicals
that were carcinogenic in any sex-species
group was 0.59, which was larger than the
NTP proportion of 0.51. However, the
NTP value was contained in our 90%
confidence interval of0.49-0.69.
Our estimates of the proportion of
anticarcinogens in sex-species groups
ranged from 0.27 to 0.44 (Table 2).
Except for female mice, these estimates
were larger than our corresponding esti-
mates of the proportion of carcinogens.
We estimated that 0.66 of the chemicals
were anticarcinogenic in at least one
sex-species group. Our estimates of the
proportion of chemicals that were either
iM carcinogenic or anticarcinogenic in
1|1_E S w4<jT5t5 j;S sex-species groups ranged from 0.57 to
0.67. We estimated that 85% [95% con-
fidence interval (ClI), 78-91%] of chemi-
cals were either carcinogenic or anticar-
0.4 0.6 0.8 1 cinogenic in at least one sex-species
a .. group.
Male Discussion
Using methods similar to those employed
ijs here, Crump et al. (10J estimated a con-
siderably larger proportion of liver car-
cinogens in NTP studies (0.43; 90% CI,
-n#;ff # g 0.35-0.51) than was identified by the
NTP (0.28). We had expected to find
02 0.4 1 similar evidence in the present study for
an excess ofchemicals carcinogenic at any
Female rate site, but we did not. In retrospect, we
mm believe this difference is due mainly to the = manner in which the NTP evaluated
studies. The NTP tended to evaluate the
data for each tumor category individually
in order to determine whether there was a
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treatment-related increase in tumors at
0 0.2 OA 0.6 0.8 1 0 0.2 04 0.6 08 that site. A chemical was labeled a car-
*a a cinogen if it was deemed to be carcino-
All sexe and All exesx anbd specua genic at any site. It is clearly more likely
that a chemical will be labeled a carcino-
Mgen at some site using this procedure than
S _ = _ _ _ ; _ ] ~~~~~~~~~~~~~~~~~~at a particular site (e.g. liver). Expressed
r. 4 differently, the NTP did not use a formal
method for correcting for multiple com-
~~~~ ~~~~~~ r ~~~~~~~parisons and consequently may have been
WM.R prone to accept weaker statistical evidence
GAee 0oi.8 § 0.8 1 6@ 0.2 0.8e 0.8 -; 1 for an effect at any tumor site than for an
a effect at a particular site. In contrast, our
e3. Estimates ofthe proportion ofcarcinogens in Figure 4. Estimates of the proportion of anticarcino- analysis did adjust appropriately for mul-
bioassays. Thin lines indicate 90% confidence gens in NTP bioassays. Thin lines indicate 90% confi- tiple comparisons, as evidenced by the
Pals. Blackhorizontal lines indicate NTP estimate. dence intervals. uniform distribution ofp-values in the
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null situation (Fig. 1). We recommend that
the NTP consider formally adjusting for
multiple comparisons in their statistical
analysis, just as we have done. Such an
approach would make determinations of
statistical significance more easily interpret-
ed and could lead to more equitable classi-
fications of carcinogenic responses across
different sex-species groups.
Another factor that may have con-
tributed to our finding a larger proportion
ofliver carcinogens than the NTP stemmed
from the high frequency of dose-related
increases among liver tumors and the occur-
rence of some of these tumors through
mechanisms that were ofquestionable rele-
vance to humans. To compensate, the NTP
may have used more stringent criteria for
evaluating liver tumors than tumors at
other sites.
Although we did not find evidence for
larger proportions ofcarcinogens than were
identified by the NTP, there were differ-
ences between our findings and those of
the NTP for individual chemicals (Table
1). Based on using a conventional signifi-
cance level of0.05 in our analysis, the over-
all concordance between our analysis and
the NTP ranged from 0.91 for male mice
to 0.85 for male rats. We were not able to
improve this degree ofconcordance appre-
ciably by using different significance levels
for our analysis. There are a number of
potential reasons for these differences.
Whereas we used a single statistical test for
trend in our analysis (the POLY3 test), the
NTP used a variety of statistical tests,
including pairwise comparisons. The NTP
pooled control groups from several studies
in their statistical evaluations of some of
the earlier studies. We did not have com-
plete records for identifying these pooled
controls and consequently used matched
controls in our analyses of some of these
studies. The NTP sometimes took into
account historical control data, but we did
not. In some instances, the NTP took into
account data that were not available in
CBDS or TDMS. For example, in some
equivocal situations, the NTP collected
additional kidney pathology that was not
added to CBDS or TDMS. In at least one
study, an entire group of dosed animals
that was critical to the NTP evaluation was
not induded in CBDS or TDMS. Whereas
we evaluated sex-species groups in isola-
tion, the NTP sometimes labeled an
insigniflcant trend in a particular sex as
clear evidence ofcarcinogenicity ifthe evi--
dence at the same site in the opposite sex
was unequivocal. Male rats had a high
background rate of testicular tumors, and
dose-related trends in these tumors general-
ly were not taken into account by the
Table 2. Representative estimatesa (with 90% confidence intervals) of the proportion of chemicals that
were carcinogenic, anticarcinogenic, or either
Carcinogenic
This study NTP
Male mice 0.32 (0.19-0.44) 0.29
Female mice 0.28 (0.15-0.41) 0.35
Male rats 0.35 (0.23-0.47) 0.36
Female rats 0.34 (0.21-0.46) 0.28
All sexes and species 0.59 (0.49-0.69) 0.51
&Based on the estimator K(a),with a = 0.75.
NTP. (However, removing chemicals from
our analysis for which the strongest effect
was seen in these tumors did not apprecia-
bly approve the concordance between our
analysis and that ofthe NTP.) It should be
kept in mind that it was not the purpose of
the present work to critique NTP classifica-
tions ofindividual chemicals, but rather to
make independent estimates ofthe propor-
tion of chemicals that were carcinogenic,
anticarcinogenic, or either based on the
information contained in the CBDS or
TDMS databases. The data and procedures
we used provide a statistically valid method
for deriving such estimates.
In a similar study that estimated the
number of liver carcinogens in the NTP
database (1O), the presence of anticarcino-
genic effects caused the CDFs ofp-values to
fall belowthe graphy = xforvalues ofpnear
1.0. This effect was a source of additional
negative bias in the (one-point) estimator,
K(a). To minimize this effect, Crump et al.
(JI) used the "two-point estimator,"
K(a,b) = [bF(a) - aF(b)]/[b -a],
where a and b are two judiciously chosen
points between 0 and 1.0. This estimator
reduces to the one-point estimator, K(a),
used in the present study when b = 1.0.
This refinement was not needed in the pre-
sent study because, except possibly for
female mice, the CDFs do not exhibit an
effect of anticarcinogenesis (Fig. 2). The
reason for this was that in the present study
the test statistic was the maximum ofindi-
vidual test statistics computed from each
individual tumor type. The maximum test
statistic over several tumor sites will be less
affected by anticarcinogenic activity at one
or a few sites than a test statistic for a single
site will be affected by anticarcinogenesis at
that site. Thus, in this respect, estimation
of the proportion of experiments that
showed carcinogenic activity at any site was
simpler than estimating the corresponding
proportion for a particular site.
In the previous study ofliver carcinogens
(10), p-value CDFs simulated for the null
case exhibited irregularities due to the dis-
creteness ofthe data. This was particularly a
Anticarcinogenic
0.34 (0.21-0.46)
0.27 (0.14-0.40)
0.40 (0.28-0.52)
0.44 (0.32-0.56)
0.66 (0.56-0.75)
Either
0.58 (0.48-0.68)
0.57 (0.46-0.67)
0.61 (0.51-0.71)
0.67 (0.58-0.76)
0.85 (0.78-0.91)
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Figure 5. Estimates of the proportion of chemicals that
were either carcinogenic or anticarcinogenic in NTP
bioassays. Thin lines indicate90% confidence intervals.
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problem for female rats, which exhibited the
smallest spontaneous rates of liver tumors.
Such irregularities are not apparent in the
simulated null distributions in the present
study (Fig. 1). This difference is due to the
fact that in the present study the test statistic
was defined as the maximum value obtained
from analysis of a number of individual
tumor categories. The average number of
tumor categories analyzed ranged from 12 in
male mouse CBDS studies to 30 in male rat
TDMS studies. Defining the test statistic as
the maximum ofalarge number oftest statis-
tics gave a denser range ofpossiblep-values,
which resulted in a test statistic thatwas more
uniformly distributed in the null case, than
defining the test statistic in terms ofonly a
single tumor category.
The present study found evidence for a
larger proportion of anticarcinogens than
carcinogens among NTP chemicals. An
analysis that used a conventional signifi-
cance level of 0.05 to detect effects would
not have found this because the proportion
of chemicals having a p-value <0.05 for
anticarcinogenesis was smaller than the cor-
responding proportion for carcinogenesis
in every group except female rats.
Nevertheless, the overall distribution ofp-
values provided evidence for a larger pro-
portion of anticarcinogens. We estimated
that 66% of NTP chemicals were anticar-
cinogenic in at least one site in at least one
sex-species group. Finding a larger propor-
tion of anticarcinogens than carcinogens
was surprising to us because chemicals were
selected for study by the NTP on the basis
of suspected carcinogenicity and also
because anticarcinogenesis should be inher-
ently more difficult to detect than carcino-
genesis in NTP bioassays. More than 90%
ofthe background incidences ofthe tumor
categories used in our analysis were less
than 0.05. It would be difficult to detect
dose-related decreases in tumor responses
in a tumor category with a background rate
as small as 0.05.
Haseman and Johnson (13) concluded
that much ofthe anticarcinogenesis seen in
NTP bioassays was indirectly caused by a
dose-related reduction in weight gain. This
mechanism may not be operative except at
very high doses. However, this uncertainty
is not limited to this mechanism or even
anticarcinogenesis, as there is generally
uncertainty regarding whether an effect
seen in a high-dose NTP bioassay, either
carcinogenic or anticarcinogenic, will occur
at lower doses.
This study estimated that 85% of the
chemicals studied by the NTP were either
carcinogenic or anticarcinogenic at some
site in some sex-species group ofrodents. It
should be kept in mind that the estimator
used to obtain this estimate is inherently
negatively biased. This suggests that most
chemicals, when given at sufficiently high
doses, may cause perturbations that affect
tumor responses, causing increases at some
sites and decreases at others. These effects
will undoubtedly be smaller at lower doses,
but identification ofdoses at which they do
not occur will be highly problematic.
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